Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Healius Limited ( (AU:HLS) ) just unveiled an update.
Healius Limited has released its corporate governance statement for the financial year ending June 30, 2025. The statement, approved by the board, outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations. This disclosure is part of Healius’s commitment to transparency and accountability in its operations, potentially enhancing stakeholder trust and reinforcing its market position.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.87 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited operates in the healthcare industry, providing medical and diagnostic services. The company focuses on delivering quality healthcare solutions and is listed on the Australian Securities Exchange (ASX).
Average Trading Volume: 4,967,969
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$548.2M
See more data about HLS stock on TipRanks’ Stock Analysis page.